PŘEHLEDOVÉ ČLÁNKY Infekční komplikace syndromu diabetické nohy – diagnostika a léčba 30 | VNITŘNÍ LÉKAŘSTVÍ / Vnitř Lék. 2023;69(1):25-30 / www.casopisvnitrnilekarstvi.cz in the Period 2009(-)2013: A Retrospective Descriptive Analysis. Int J Environ Res Public Health. 2018;15(9). 9. Lipsky BA, Senneville E, Abbas ZG, Aragon‑Sanchez J, Diggle M, Embil JM, et al. Guide‑ lines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36 (Suppl) 1:e3280. 10. Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infec‑ tious Diseases Society of America’s diabetic foot infection classification system. Clin In‑ fect, DiS. 2007;44(4):562-5. 11. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29(6):1288-93. 12. Wang A, Lv G, Cheng X, Ma X, Wang W, Gui J, et al. Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition). Burns Trauma. 2020;8:tkaa017. 13. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syn‑ drome: evaluating the prevalence and incidence of foot pathology in Mexican Ameri‑ cans and non‑Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26(5):1435-8. 14. Daneshvar K, Anwander H. Diagnostic Imaging of Diabetic Foot Disorders. Foot An‑ kle Clin. 2022;27(3):513-27. 15. Wukich DK, Johnson MJ, Raspovic KM. Limb Salvage in Severe Diabetic Foot Infecti‑ on. Foot Ankle Clin. 2022;27(3):655-70. 16. Reiner MM, Khoury WE, Canales MB, Chmielewski RA, Patel K, Razzante MC, et al. Pro‑ calcitonin as a Biomarker for Predicting Amputation Level in Lower Extremity Infections. J Foot Ankle Surg. 2017;56(3):484-91. 17. Jeandrot A, Richard JL, Combescure C, Jourdan N, Finge S, Rodier M, et al. Serum pro‑ calcitonin and C‑reactive protein concentrations to distinguish mildly infected from non ‑infected diabetic foot ulcers: a pilot study. Diabetologia. 2008;51(2):347-52. 18. Lavery LA, Ahn J, Ryan EC, Bhavan K, Oz OK, La Fontaine J, et al. What are the Opti‑ mal Cutoff Values for ESR and CRP to Diagnose Osteomyelitis in Patients with Diabetes ‑related Foot Infections? Clin Orthop Relat Res. 2019;477(7):1594-602. 19. Zhang WQ, Tang W, Hu SQ, Fu XL, Wu H, Shen WQ, et al. C‑reactive protein and diabetic foot ulcer infections: A meta‑analysis. J Tissue Viability. 2022;31(3):537-43. 20. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Dia‑ gnosis and treatment of diabetic foot infections. Plast Reconstr Surg. 2006;117(7 Suppl):212S-38S. 21. Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA. Bacteriology of moderate‑to‑severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol. 2007;45(9):2819-28. 22. Fejfarova V, Jirkovska A, Petkov V, Boucek P, Skibova J. Comparison of microbial findings and resistance to antibiotics between transplant patients, patients on he‑ modialysis, and other patients with the diabetic foot. J Diabetes Complications. 2004;18(2):108-12. 23. Mandell JC, Khurana B, Smith JT, Czuczman GJ, Ghazikhanian V, Smith SE. Osteomye‑ litis of the lower extremity: pathophysiology, imaging, and classification, with an empha‑ sis on diabetic foot infection. Emerg Radiol. 2018;25(2):175-88. 24. Giurato L, Meloni M, Izzo V, Uccioli L. Osteomyelitis in diabetic foot: A comprehensive overview. World J Diabetes. 2017;8(4):135-42. 25. Chou YY, Hou CC, Wu CW, Huang DW, Tsai SL, Liu TH, et al. Risk factors that predict major amputations and amputation time intervals for hospitalised diabetic patients with foot complications. Int Wound J. 2022;19(6):1329-38. 26. Lam K, van Asten SA, Nguyen T, La Fontaine J, Lavery LA. Diagnostic Accuracy of Pro‑ be to Bone to Detect Osteomyelitis in the Diabetic Foot: A Systematic Review. Clin In‑ fect, DiS. 2016;63(7):944-8. 27. Berendt AR, Peters EJ, Bakker K, Embil JM, Eneroth M, Hinchliffe RJ, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Dia‑ betes Metab Res Rev. 2008;24 Suppl 1:S145-61. 28. Embil JM, Trepman E. Microbiological evaluation of diabetic foot osteomyelitis. Clin Infect, DiS. 2006;42(1):63-5. 29. Lavery LA, Sariaya M, Ashry H, Harkless LB. Microbiology of osteomyelitis in diabetic foot infections. J Foot Ankle Surg. 1995;34(1):61-4. 30. Lipsky BA, Berendt AR, Embil J, De Lalla F. Diagnosing and treating diabetic foot infec‑ tions. Diabetes Metab Res Rev. 2004;20 Suppl 1:S56-64. 31. Sella EJ, Grosser DM. Imaging modalities of the diabetic foot. Clin Podiatr Med Surg. 2003;20(4):729-40. 32. Berendt AR, Lipsky B. Is this bone infected or not? Differentiating neuro‑osteoarthropathy from osteomyelitis in the diabetic foot. Curr Diab Rep. 2004;4(6):424-9. 33. Zhan LX, Branco BC, Armstrong DG, Mills JL, Sr. The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot In‑ fection (WIfI) correlates with risk of major amputation and time to wound healing. J Vasc Surg. 2015;61(4):939-44. 34. Ince P, Abbas ZG, Lutale JK, Basit A, Ali SM, Chohan F, et al. Use of the SINBAD classifi‑ cation system and score in comparing outcome of foot ulcer management on three con‑ tinents. Diabetes Care. 2008;31(5):964-7. 35. Lavery LA, Ryan EC, Ahn J, Crisologo PA, Oz OK, La Fontaine J, et al. The Infected Dia‑ betic Foot: Re‑evaluating the Infectious Diseases Society of America Diabetic Foot Infec‑ tion Classification. Clin Infect, DiS. 2020;70(8):1573-9. 36. Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, Boulton AJ, Harkless LB. Off‑loading the diabetic foot wound: a randomized clinical trial. Diabetes Care. 2001;24(6):1019-22. 37. Hinchliffe RJ, Forsythe RO, Apelqvist J, Boyko EJ, Fitridge R, Hong JP, et al. Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36 Suppl 1:e3276. 38. Lipsky BA. Empirical therapy for diabetic foot infections: are there clinical clues to gu‑ ide antibiotic selection? Clin Microbiol Infect. 2007;13(4):351-3. 39. Uckay I, Berli M, Sendi P, Lipsky BA. Principles and practice of antibiotic stewardship in the management of diabetic foot infections. Curr Opin Infect, DiS. 2019;32(2):95-101. 40. Jeffcoate WJ. Osteomyelitis of the foot: non‑surgical management, SPECT/CT scan‑ ning and minimising the duration of antibiotic use. Diabetologia. 2017;60(12):2337-40. 41. Chatzipapas C, Karaglani M, Papanas N, Tilkeridis K, Drosos GI. Local Antibiotic Delivery Systems in Diabetic Foot Osteomyelitis: A Brief Review. Rev Diabet Stud. 2021;17(2):75-81. KNIŽNÍ NOVINKA Akutní stavy ve vnitřním lékařství, 2. vydání Jan Vachek, Vít Motáň, Oskar Zakiyanov, Jiří Motáň, Hana Ciferská, Zdeněk Hess, Vladimír Tesař a kol. Příručka praktické medicíny určená především mladým lékařům, napsaná kolektivem internistů se zkušenostmi zá‑ roveň jak z fakultních pracovišť, tak i z menších nemocnic a z terénní praxe. Cílem publikace je poskytnout rychlou odpověď na nejčastější akutní klinické problémy, nejen v oblasti vnitřního lékařství, ale i v souvisejících oborech, jako je např. neurologie, psychiatrie. Kniha tak vychází vstříc rovněž aktuálním potřebám internistů na příjmových ambulancích, kde je třeba řadu akutních stavů skutečně řešit a ne je jen odeslat. Snahou autorů bylo vytvořit příručku, jakou by si sami byli přáli mít k dispozici v době, kdy nastoupili do zaměstnání. Spoluautorem nebo recenzentem každé kapitoly je odborník specializující se na danou problematiku. V současnosti jde o jedinou aktuální publikaci svého druhu na domácím knižním trhu. Publikace obsahuje konkrétní návody jak postupovat v jednotlivých akutních stavech. Maxdorf 2022, 544 str., edice Jessenius ISBN 978-80-7345-746-4 Cena: 895 Kč Formát: 125 × 190 mm, brožovaná
RkJQdWJsaXNoZXIy NDA4Mjc=